Why Leadership, Not Protocols, Defines The Future Of Clinical Research

The future of clinical research depends on people just as much as strong systems and processes. Learn what makes great ...

GCCL and OPIS Announce Strategic Collaboration to Advance Global Clinical Trial Capabilities

Through this collaboration, GCCL aims to expand strategic partnerships with global CROs and research organizations, strengthen its capability to deliver fully integrated clinical trial solutions ...

Enhancing Clinical Efficiency Through Master Protocol Trial Design, Upcoming Webinar Hosted by Xtalks

Running separate protocols for multiple investigational products and disease subpopulations slows development and duplicates infrastructure. There is growing interest in accelerating drug development ...
FierceBiotech

Risklick debuts new AI software that writes clinical trial protocols

A Swiss startup called Risklick has launched artificial intelligence software for clinical trials that the company claims can reduce development time and costs by as much as 35%, according to an April ...

American Oncology Research and MiBA Form Strategic Alliance to Integrate Real-Time Data Intelligence with Community-Based Clinical Research

The collaboration addresses a longstanding challenge in the pharmaceutical industry: the disconnect between static clinical ...
JD Supra

FDA warns of “important” clinical trial protocol deviations

The U.S. Food and Drug Administration (FDA) published the draft guidance “Protocol Deviations for Clinical Investigations of Drugs, Biological Products, and Devices,” which provides advice for ...

Avinasi Labs Brings Disease-Specific Data Lakes On-Chain via DeLong Protocol, Through Collaboration with ECODI Meditech

SAN FRANCISCO, CA, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Avinasi Labs, an AI-native longevity infrastructure company building the world’s first liquid foundation model for ageing ...
FierceBiotech

Market Insights: What’s Driving the Shift Toward FSP Models in Clinical Development?

As advancements in medical science progress, clinical research and development (R&D) are subject to more sophisticated and complex study designs and protocols that require precise global coordination ...
STAT

Trial by fire: More study protocols are experiencing substantial — and costly — changes

Over the past several years, the number of deviations and substantial amendments made to clinical trial protocols has increased notably, contributing to delays in drug development and rising costs for ...
Nasdaq

Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat Long COVID

TORONTO, June 12, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and ...
JD Supra

Federal Court Invalidates Dosing Patent Based On Clinical Trials Disclosure

As an essential component of the drug development process, human clinical trials assist in determining whether a given drug will serve its intended purpose, but patent applicants should consider ...